Barbara Weber, Chief Executive Officer at Tango Therapeutics, Inc. (TNGX), sold 18,276 shares at $12.56 ($230K) on 2024-02-06, disclosed to the SEC on 2024-02-08.
Open-market sale of $230k TNGX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.56 | 4,681 | $59K | 25.6% |
| 2 | $12.56 | 4,681 | $59K | 25.6% |
| 3 | $12.62 | 4,457 | $56K | 24.4% |
| 4 | $12.62 | 4,457 | $56K | 24.4% |
| Total | $12.59 avg | 18,276 | $230K | 100% |
| Filing → |
| RVMD | SELL | 2024-10-10 | $499K | — | Filing → |
| RVMD | SELL | 2023-09-06 | $526K | — | Filing → |
| RVMD | SELL | 2021-02-05 | $252K | — | Filing → |